Intermittent Claudication

• FDA approval · 2020-11-16
  FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

  FDA approves a supplemental application for Cilostazol submitted by Apotex Corp., updating the drug's approval status.

• FDA approval · 2020-11-02
  FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for pentoxifylline submitted by Rising Pharma Holdings, Inc., indicating an approved change related …

• FDA approval · 2017-12-01
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for cilostazol submitted by Chartwell RX, LLC.

• FDA approval · 2017-12-01
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA granted a supplemental approval for cilostazol by Chartwell RX, LLC under the ANDA process.

• FDA approval · 2016-04-04
  FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

  The FDA approval of a supplemental application for cilostazol from Apotex Corp., enabling continued generic supply under the approved scope.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-04-04
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for Cilostazol from Chartwell RX, LLC under an ANDA.

• FDA approval · 2016-04-04
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc. This action updates the regulatory status…

• FDA approval · 2016-04-04
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for cilostazol from Chartwell RX, LLC.

• FDA approval · 2016-01-21
  FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)

  The FDA approved a supplemental application for pentoxifylline filed by Rising Pharma Holdings, Inc., indicating an update to its regulatory…

• FDA approval · 2014-12-31
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Cilostazol (generic Cilostazol). This action typically involves u…

• FDA approval · 2014-11-06
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for cilostazol submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to the drug's l…

• FDA approval · 2014-09-23
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Cilostazol from Teva Pharmaceuticals USA, Inc., updating the labeling for the drug. This constit…

• FDA approval · 2012-03-09
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's supplemental application for Cilostazol, enabling the generic Cilostazol product to be marketed.

• FDA approval · 2008-08-29
  FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Cilostazol from Apotex Corp., authorizing the marketing of a generic cilostazol product.

• FDA approval · 2008-06-27
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for cilostazol filed by Teva Pharmaceuticals USA, Inc.

• FDA approval · 2008-03-10
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approves Chartwell RX, LLC's supplemental application for cilostazol (generic) under ANDA077021, enabling market authorization for a gen…

• FDA approval · 2008-03-10
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for cilostazol filed by Chartwell RX, LLC.

• FDA approval · 2007-01-12
  FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)

  The FDA approved a supplemental application for Pentoxifylline submitted by Rising Pharma Holdings, Inc., enabling continued marketing of th…

• FDA approval · 2006-12-07
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc., related to the approved Cilostazol p…

• FDA approval · 2006-05-08
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved Teva's supplemental application for cilostazol (generic) under ANDA077027.